News
News

The latest updates from AFAR.

Board member in the News: Today Show spotlights Nir Barzilai and the TAME Trial

Sep 14
2017

Board member in the News: Today Show spotlights Nir Barzilai and the TAME Trial View MoreBACK

On Friday, September 8, 2017, NBC Today Show featured a segment with correspondent Maria Shriver spotlighting AFAR Deputy Scientific Director and multiple grantee Nir Barzilai, MD on the potential of the TAME (Targeting Aging with Metformin) Trial .

Shot at Dr. Barzilai’s lab at Einstein College of Medicine, the segment explores the potential for drugs that target aging, like Metformin, to extend healthspan.

Their dialogue stresses if the FDA considers aging an indication for such interventions, many more promising drugs are ready to be tested and brought to the market, transforming how we can all live healthier as we grow older.

Watch the clip here.

Nir Barzilai, MD, is the Director of the NIA Nathan Shock Center of Excellence in the Basic Biology of Aging, the Paul F. Glenn Center for the Biology of Aging, and the Institute for Aging Research at Albert Einstein College of Medicine.


Learn more about the AFAR-managed TAME Trial here.
 





View MoreBACK TO TOP